The significance of CO2 combining power in predicting prognosis of patients with stage II and III colorectal cancer

Biomark Med. 2019 Sep;13(13):1071-1080. doi: 10.2217/bmm-2018-0321. Epub 2019 Sep 9.

Abstract

Aim: This study was to evaluate whether CO2CP level in venous blood could predict prognosis of patients with colorectal cancer (CRC). Materials & methods: A retrospective cohort of 238 patients with CRC who received surgical resection and 176 CRC Stage IV patients were included. A total of 114 healthy people were recruited as control. CO2CP levels were obtained from medical records. Survival analysis was performed to evaluate CO2CP predictive potential. The patients were divided into CO2CP high or low group based on CO2CP optimal cut-off values. Conclusion: The decreased CO2CP in CRC patients was associated with advanced clinical stage, and suggested that decreased CO2CP may predict the worse outcomes of disease-free survival in II/III stage CRC patients.

Keywords: CA199; CO2 combing power; TNM stage; acidity; colorectal cancer; disease-free survival; metastasis; prognosis; sensitivity; specificity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Area Under Curve
  • Carbon Dioxide / blood*
  • Case-Control Studies
  • Colorectal Neoplasms / mortality
  • Colorectal Neoplasms / pathology*
  • Disease-Free Survival
  • Female
  • Humans
  • Kaplan-Meier Estimate
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Prognosis
  • ROC Curve
  • Retrospective Studies

Substances

  • Carbon Dioxide